Skip to main content
. 2023 Jul 13;10:1219788. doi: 10.3389/fcvm.2023.1219788

Table 1.

Outcomes.

  Hybrid group Conventionally treated group p
Perioperative period
Death 2/72 (2.78%) 5/46 (10.87%) 0.0696
Paraplegia 0/72 (0.00%) 2/46 (4.35%) 0.0743
Renal failure 1/72 (1.39%) 17/46 (36.96%) <0.0001
Unilateral renal infarction 5/72 (6.94%) 4/46 (8.70%) 0.7267
Intestinal paralysis/necrosis 1/72 (1.39%) 4/46 (8.70%) 0.0546
Respiratory failure 0/72 (0.00%) 5/46 (10.87%) 0.0043
Deep venous thrombosis 0/72 (0.00%) 4/46 (8.70%) 0.0109
Postoperative follow-up
Death 5/70 (7.14%) 4/41 (9.76%) 0.6264
Unplanned reoperation 3/70 (4.29%) 6/41 (14.63%) 0.0539
Surgical/aneurysm-related deaths 7/72 (9.72%) 9/46 (19.57%) 0.1277